Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Stacie Jones

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Jones, Stacie

Item TypeName
Academic Article Egg oral immunotherapy in nonanaphylactic children with egg allergy.
Academic Article Peanut oral immunotherapy is not ready for clinical use.
Academic Article Egg oral immunotherapy in non-anaphylactic children with egg allergy: follow-up.
Academic Article Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.
Academic Article Tree nut- and sesame-specific IgE do not decrease from baseline with peanut oral immunotherapy (OIT).
Academic Article Adverse reactions during peanut oral immunotherapy home dosing.
Academic Article Clinical efficacy and immune regulation with peanut oral immunotherapy.
Academic Article Oral immunotherapy for treatment of egg allergy in children.
Academic Article Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report.
Academic Article Oral tolerance, food allergy, and immunotherapy: implications for future treatment.
Academic Article Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
Academic Article An update on immunotherapy for food allergy.
Academic Article Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
Academic Article A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
Academic Article Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.
Academic Article Oral immunotherapy for food allergy.
Academic Article Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance.
Concept Immunotherapy
Academic Article Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Academic Article State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous.
Academic Article A randomized, double-blind, placebo-controlled, multicenter trial of egg oral immunotherapy in children: An analysis of clinical tolerance
Academic Article Peanut oral immunotherapy for peanut allergic subjects
Academic Article Peanut oral immunotherapy (OIT) modified rush: low dose vs high dose
Academic Article Camparison of sublingual immunotherapy (SLIT) versus oral immunotherapy (OIT) in the treatment of peanut allergy
Academic Article Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial (CoFAR
Academic Article Oral peanut immunotherapy for peanut allergic patients
Academic Article Basophil suppression in peanut allergy patients undergoing peanut oral immunotherapy (OIT)
Academic Article Peanut oral immunotherapy (OIT) induces epitope-specific isotype shift from IgE to IgG4
Academic Article Immunoglobulin changes using different dosing regimens of peanut oral immunotherapy (OIT) in peanut allergic subjects
Academic Article Oral peanut immunotherapy for children with peanut allergy
Academic Article Double-blind, placebo-controlled (DBPC) trial of oral immunotherapy (OIT) in peanut allergic children
Academic Article Mean wheal size from peanut prick skin test and IgE levels in peanut allergic patients receiving oral peanut immunotherapy
Academic Article Peanut oral immunotherapy (OIT) induces immunologic changes supporting the development of tolerance
Academic Article Safety of oral peanut immunotherapy for peanut allergic patients
Academic Article Regulatory T-cell patterns and cytokine profiles suggest the development of tolerance in patients undergoing peanut oral immunotherapy (OIT)
Academic Article Tree nut and sesame-spcific IgE do not decrease with peanut oral immunotherapy (OIT)
Academic Article A randomized controlled study of peanut oral immunotherapy (OIT): clinical desensitization and modulation of the allergic response
Academic Article Safety of Peanut Oral Immunotherapy (OIT)
Academic Article Peanut Oral Immunotherapy (OIT) confers long-term tolerance mediated by decreased T-helper Type 2 (TH2) cytokines and cytokines generated by regulatory T cells (Tregs)
Academic Article Early and persistent gastrointestinal side effects predict withdrawal from Peanut Oral Immunotherapy (OIT)
Academic Article Double-blind, placebo-controlled trial of oral immunotherapy (OIT) in peanut (PN) allergic children: A follow-up
Academic Article Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in humans
Academic Article Oral immunotherapy (OIT) induces clinical tolerance in peanut-allergic children
Academic Article Threshold dose for peanut allergy during peanut oral immunotherapy procedure in children
Academic Article Peanut Oral Immunotherapy (OIT) induces a transient increase in CD4+CD25+FoxP3+ Tregs and a sustained decrease of Th2-type cytokines
Academic Article Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Academic Article Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.
Academic Article Diagnosis, management, and investigational therapies for food allergies.
Academic Article Current and Emerging Therapies for IgE-Mediated Food Allergy.
Academic Article Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch.
Academic Article Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.
Academic Article Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.
Academic Article Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Academic Article Food Allergy.
Academic Article Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
Academic Article AR101 Oral Immunotherapy for Peanut Allergy.
Grant Arkansas Center for Food Allergy Research (ArCOFAR)
Academic Article Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Academic Article A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol.
Academic Article Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.
Academic Article Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Academic Article Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
Academic Article Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Academic Article Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Academic Article Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
Academic Article Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Academic Article Cracking the Nut: Oral Immunotherapy Conundrums.
Academic Article Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy.
Academic Article HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success.
Academic Article Food Allergen Immunotherapy in Preschool Children: Do We Have the Evidence?
Academic Article Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
Academic Article Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults?(OUtMATCH) Clinical Trial.
Academic Article Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Grant Peanut Oral Immunotherapy Induces Long-Lasting Immune Tolerance (ACHRI # 034229)
Academic Article Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.
Academic Article Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.

Search Criteria
  • Immunotherapy